2020
DOI: 10.4168/aair.2020.12.6.910
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation and Management of Difficult-to-Treat and Severe Asthma: An Expert Opinion From the Korean Academy of Asthma, Allergy and Clinical Immunology, the Working Group on Severe Asthma

Abstract: Severe asthma (SA) presents in about 3%–5% of adult asthmatics and is responsible for over 60% of asthma-related medical expenses, posing a heavy socioeconomic burden. However, to date, a precise definition of or clear diagnostic criteria for SA have not been established, and therefore, it has been challenging for clinicians to diagnose and treat this disease. Currently, novel biologics targeting several molecules, such as immunoglobulin E, interleukin (IL)5, and IL4/IL13, have emerged, and many new drugs are … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
16
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
10

Relationship

7
3

Authors

Journals

citations
Cited by 23 publications
(18 citation statements)
references
References 77 publications
0
16
0
Order By: Relevance
“…Thus, multidisciplinary approaches are warranted to help these patients, including emotional, psychological and social support. There is a general consensus among specialist physicians that multidisciplinary care should be provided in clinics for severe asthma [ 3 , 23 26 ], but it is still unclear how this goal is being achieved, particularly how to provide a programme for physical and psychosocial support to the patients. Patient groups for severe asthma, where patients could meet and share experiences, may be helpful in supporting their psychosocial well-being.…”
Section: Discussionmentioning
confidence: 99%
“…Thus, multidisciplinary approaches are warranted to help these patients, including emotional, psychological and social support. There is a general consensus among specialist physicians that multidisciplinary care should be provided in clinics for severe asthma [ 3 , 23 26 ], but it is still unclear how this goal is being achieved, particularly how to provide a programme for physical and psychosocial support to the patients. Patient groups for severe asthma, where patients could meet and share experiences, may be helpful in supporting their psychosocial well-being.…”
Section: Discussionmentioning
confidence: 99%
“…Severe asthma comprises approximately 4-10% of patients with asthma, [1][2][3][4] and 20-60% of patients with severe asthma need regular use of a systemic corticosteroid (CS) due to uncontrolled asthmarelated symptoms or frequent exacerbations. [5][6][7] Patients with CS-dependent asthma show an increased use of healthcare resources and higher mortality than other patients with asthma.…”
Section: Introductionmentioning
confidence: 99%
“…Our study results provide an important clinical implication that control of both lipid profiles and obesity may be more effective for prevention and treatment of asthma with the obesity phenotype. 20 …”
Section: Discussionmentioning
confidence: 99%